FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely to neurology, and can be used for treating dementia, and pre-dementia related conditions. Methods under the inventions involve introducing in an individual at least one polyunsaturated fatty acid (PUFA) or its precursor, or a source, where the PUFA is specified in a group consisting of docosahexaenoic acid (DHA); docosapentaenoic acid (DPAn-6); a combination of DHA and DPAn-6; a combination of DHA and arachidonic acid (ARA) and a combination of DHA, DPAn-6 and ARA.
EFFECT: use of the inventions provides treating dementia, and pre-dementia related conditions due to reducing an amount of tau protein, presenilin-1 (PS1), delayed demyeliniation and neurofibrillary tangle formation.
55 cl, 3 tbl, 10 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
NON-MEDICAL INCREASE OR MAINTENANCE OF BODY WEIGHT OF A MAMMAL | 2011 |
|
RU2647461C2 |
COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF INDISPOSITION | 2011 |
|
RU2646830C2 |
EFFICACY OF FOOD DHA-PHOSPHOLIPID FOR BRAIN DHA AND DPA ACCRETION IN NEONATES | 2014 |
|
RU2662777C2 |
BABY FOOD FOR IMPROVING FATTY ACIDS COMPOSITION IN CEREBRAL CELL MEMBRANES | 2011 |
|
RU2692920C2 |
INFANT FOOD FOR IMPROVEMENT OF FATTY ACIDS COMPOSITION IN BRAIN CELL MEMBRANES | 2011 |
|
RU2559113C2 |
METHOD AND PREPARATION FOR THE TREATMENT OR PREVENTION OF ANXIETY OR NEUROGENESIS | 2010 |
|
RU2606841C2 |
BABY FOOD FOR IMPROVING FATTY ACIDS COMPOSITION IN CEREBRAL CELL MEMBRANES | 2011 |
|
RU2692627C2 |
BALANCED FAT COMPOSITIONS AND THEIR APPLICATION IN LIQUID NUTRITIONAL COMPOSITIONS FOR ENTERAL FEEDING | 2010 |
|
RU2546865C2 |
LIPIDS CONTAINING FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2004 |
|
RU2362566C2 |
COMPOSITIONS CONTAINING PUFA AND/OR URIDINE, AND METHODS OF APPLICATION THEREOF | 2006 |
|
RU2429851C2 |
Authors
Dates
2012-03-10—Published
2006-07-07—Filed